×
The Standard Group Plc is a multi-media organization with investments in media platforms spanning newspaper print operations, television, radio broadcasting, digital and online services. The Standard Group is recognized as a leading multi-media house in Kenya with a key influence in matters of national and international interest.
  • Standard Group Plc HQ Office,
  • The Standard Group Center,Mombasa Road.
  • P.O Box 30080-00100,Nairobi, Kenya.
  • Telephone number: 0203222111, 0719012111
  • Email: [email protected]

5.75 million Kenyans vaccinated against Covid-19 so far

Kenya has so far vaccinated 5.75 million people against Covid-19, the Ministry of Health has said.

Out of this number, 3.83 million people have received the first jab, while 1.93 million are fully inoculated.

“The uptake of the second [Covid-19 vaccination] dose among those who received their first dose was at 47.1 per cent,” Health Cabinet Secretary Mutahi Kagwe said in a statement on Wednesday, November 10.

A fifth (20.7 per cent) of the Nairobi adult population has received the jab, followed by Nyeri County (18.1 per cent), Kiambu (11.4 per cent), Taita Taveta and Nyadarua counties (9.6 per cent).

Uasin Gishu County has 9.2 per cent of its adult population inoculated, Kisumu (8.3 per cent), Kirinyaga (8.2 per cent) and Mombasa (8.1 per cent).

Wajir, Mandera, and Marsabit counties had less than two per cent of their adult population vaccinated against Covid-19.

On Wednesday, Kenya received an additional 765,600 doses of AstraZeneca vaccine from the Covax facility, bringing to 10 million the number of vaccines Kenya has acquired thus far.

Kagwe said 178 people out of 7,091 samples tested positive for Covid-19 in the last 24 hours, representing a positivity rate of 2.5 per cent.

Consequently, Kenya’s caseload now stands at 254,057.

In the last 24 hours, no new deaths were recorded, with the death toll standing at 5,314.

Thirty-one (31) recovered from Covid-19, raising the total number of recoveries to 247,849.

Meanwhile, Kenya’s leading medical supply manufacturer has received funds to manufacture syringes, amid looming shortfalls besides efforts to ramp up fight against the Covid-19 pandemic Revital Healthcare (EPZ) Ltd has received $4 million (Sh400 million) from Bill & Melinda Gates Foundation to expand production of auto-disable syringes from about 72 million to 265 million annually, towards the end of 2022.

Bill & Melinda Gates Foundation estimates that the supply will cover more than half of the routine immunization needs in Africa.

Acting Health Director, Dr Patrick Amoth said the funding will enhance commodity supply security in the fight against the pandemic besides spurring economic growth and job creation. 

Most low and middle-income countries have been depending on supply of syringes from India and China, before the global pandemic which increased demand following roll-out of vaccination programs.

Related Topics


.

Trending Now

.

Popular this week